Risk Factors and Outcome of HHV-6 Infections After Allogeneic Hematopoietic Cell Transplantation
Open Forum Infectious Diseases · 30.06.2025 · 12 (7)
DOI: 10.1093/ofid/ofaf383 ↗Kurz gefasst
Fachartikel in der Zeitschrift Open Forum Infectious Diseases, online erschienen am 26.06.2025. Verfasst von Stefanie De Vlieger und 9 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Human herpesvirus 6 (HHV-6) reactivation is frequently seen in recipients of allogeneic hematopoietic cell (HCT) transplantation, but data on clinical outcomes and risk factors are scarce. We aimed to assess the epidemiological features and outcome of clinically relevant HHV-6 infections in the first 180 days after transplantation.
Methods
This was a single-center retrospective study of 405 consecutive allogeneic HCT recipients. We matched cases with a clinically relevant HHV-6 infection with control patients.
Results
We found an cumulative incidence of 3.7% (95% confidence interval [CI], 1.9-5.5) and an overall incidence rate of 8.84 per 100 person-years (95% CI, 4.95-14.6) of clinically relevant HHV-6 infections during the study period. Adjusting for HCT-specific comorbidity index category, conditioning regimen, donor type, and acute graft-versus-host disease severity, the occurrence of HHV-6 encephalitis was significantly associated with a higher hazard of nonrelapse mortality (hazard ratio, 3.821; 95% CI, 1.437-10.155; P = .007). We observed a significantly higher mortality risk for cases compared to controls (P = .04) and found female sex (P = .017) and use of steroids (P = .023) or sirolimus (P = .006) as risk factors for HHV-6 infection. All cases had lymphopenia (<500/µL) at the day of diagnosis and 80% developed acute graft-versus-host disease around the HHV-6 infection.
Conclusions
HHV-6 encephalitis remains the most detrimental disease manifestation and posttransplant factors related to immune suppression are to be included in future epidemiological studies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium.
- Biostatistics Unit, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium.
- Department of Hematology, AZ Sint-Jan Brugge AV, Brugge, Belgium.
- Department of Medical Microbiology, AZ Sint-Jan Brugge AV, Brugge, Belgium.
- Department of Nephrology and Infectious Diseases, AZ Sint-Jan Brugge AV, Brugge, Belgium.
ORCID-Profile: Ineke van Gremberghe, Tom Lodewyck, Alexander Schauwvlieghe, Marijke Reynders, Jens T Van Praet
Zitieren
APA
De Vlieger, S., Van Hoorde, J., van Gremberghe, I., Snauwaert, S., Van Droogenbroeck, J., Lodewyck, T., Schauwvlieghe, A., Selleslag, D., Reynders, M., & Van Praet, J. T. (2025). Risk Factors and Outcome of HHV-6 Infections After Allogeneic Hematopoietic Cell Transplantation. Open Forum Infectious Diseases, 12(7). https://doi.org/10.1093/ofid/ofaf383
Vancouver
De Vlieger S, Van Hoorde J, van Gremberghe I, Snauwaert S, Van Droogenbroeck J, Lodewyck T, et al. Risk Factors and Outcome of HHV-6 Infections After Allogeneic Hematopoietic Cell Transplantation. Open Forum Infectious Diseases. 2025;12(7). doi:10.1093/ofid/ofaf383
BibTeX
@article{DeVlieger2025,
author = {De Vlieger, Stefanie and Van Hoorde, Juliette and van Gremberghe, Ineke and Snauwaert, Sylvia and Van Droogenbroeck, Jan and Lodewyck, Tom and Schauwvlieghe, Alexander and Selleslag, Dominik and Reynders, Marijke and Van Praet, Jens T},
title = {Risk Factors and Outcome of HHV-6 Infections After Allogeneic Hematopoietic Cell Transplantation},
journal = {Open Forum Infectious Diseases},
year = {2025},
volume = {12},
number = {7},
doi = {10.1093/ofid/ofaf383}
}
EUVIMED